Research & Development

ERGTECH Research GmbH 

Zurich · Since 2022

Ernesto Bertarelli Foundation 

Gstaad · Since 2017

Ernesto Bertarelli Foundation supports marine conservation and scientific research, funds health and life-science research, and supports projects in local communities. It works through partnerships with scientists, NGOs and governments — including collaborations with institutions such as Harvard Medical School and the École polytechnique fédérale de Lausanne — and supports activities such as creating marine protected areas and translational neuroscience programmes.

EssDe GmbH 

Gommiswald · Since 2005

The core activity of EssDe GmbH is the development and implementation of processes and technologies for wastewater treatment, particularly with granular sludge. The company offers solutions for deammonification and the optimization of activated sludge plants through the conversion of suspended sludge into aerobic granular sludge (AGS).

etavalve GmbH 

Zürich Eth-Zentrum · Since 2020

etavalve GmbH develops a piston-based thermal engine that converts industrial waste heat (approximately 400–900 °C) into electricity using a patented variable valve actuator. The modular system is scalable from kilowatts to megawatts, achieves about 35–45% heat-to-electricity conversion, and is offered in a 20-foot container package for on-site deployment.

Etharion GmbH 

Fahrweid · Since 2012

Etharion GmbH develops and distributes teaching and learning materials based on simulation elements such as role-play games. Its main product is the simulation "politik-macht-gesetz" on the Swiss legislative process; the company also offers tailored seminars and produces accompanying instructional materials.

ETOP IBCSG Partners Foundation 

Bern · Since 2022

The core activity of ETOP IBCSG Partners Foundation is the promotion and conduct of academic, international cancer research, particularly in the field of thoracic and breast cancer. This includes organizing workshops, meetings and conferences, supporting young researchers in the development of clinical and translational research projects, as well as publishing scientific results.

Eugenex Biotechnologies GmbH 

Tägerwilen · Since 1999

Eugenex Biotechnologies GmbH develops expression cell lines and process solutions for animal component‑free production of biosimilars and novel biopharmaceuticals. The GeneXpress technology platform includes CHOSI host cell lines, protein‑free MAM‑PF media and pMOZ expression plasmids, and the company offers ready‑to‑go biosimilar processes, cell line and process development, gram‑scale protein production (non‑GMP), analytical and cell‑based assays and technology transfer.

Eurmicros GmbH 

Zurich · Since 2000

The core activity of Eurmicros GmbH is the development and design of integrated circuits (ICs) and microcontrollers, particularly for analog, digital, RF and mixed-signal applications. This also includes specific services such as the development of systems and applications, software development for microcontrollers and DSP-based systems, as well as the optimization of die areas.

EvalueScience AG 

Zurich · Since 2008

The core activity of EvalueScience AG is consulting and research for academic institutions, public institutions, associations and companies, particularly in the fields of Life Sciences, Medicine and Health.

EVIIVE AG 

Obfelden · Since 2024

EVIIVE AG develops blood-based liquid biopsy diagnostics to support the selection of immunotherapies in oncology. The company researches and builds extracellular vesicle (EV) biomarker platforms, including IMPASS and IMPACT, to profile cell-type specific EV signals and stratify patients for treatment.

EvlaBio AG 

Zurich · Since 2022

The core activity of EvlaBio AG is the development of therapeutics, particularly first-in-class therapeutics in the field of cardiovascular and cardio-renal diseases. The focus is on the development of therapeutic monoclonal antibodies (mAb) that target specific target molecules such as FGFR4/FGF23 to treat chronic kidney diseases (CKD).

EVOBIOTIX SA 

Melide · Since 2017

The core activity of EvoBiotiX is the consulting and development of biopharmaceutical products and services, particularly in the area of naturally derived bio-proteins and food derivatives. The company offers its customers from the pharmaceutical and food industries tailored solutions to drive their business and corporate development through innovative technologies. These include, among others: * Consulting services in the areas of research and development, CMC (chemistry, manufacturing and control), regulatory affairs and quality assurance * Development of joint ventures with industrial partners * Generation of own molecules based on natural products * Scouting of technologies, ingredients and suppliers * Due diligence, asset evaluation and IP evaluation * Temporary and change management services The company focuses particularly on the bridge between the food industry and the pharmaceutical industry, promoting the use of by-products and waste from the food industry for the production of biopharmaceutical products.

EvoNext Holdings SA 

Reinach Bl · Since 1997

EvoNext Holdings SA publishes investor relations information, including ad hoc announcements, financial reports and corporate governance materials. The website provides documents and disclosures intended for shareholders and the public.

Excellgene SA 

Monthey · Since 2004

ExcellGene is a Swiss Biologics-CDMO (Contract Development and Manufacturing Organization) specialized in the development and manufacturing of proteins for the pharmaceutical industry. The company's core activity encompasses providing services for the development and manufacturing of biologics, including: cell line development (CHO and HEK cells), genome engineering, cGMP cell banking, process development, ensuring clonality of existing cell lines, and biosimilars. The company supports pharmaceutical companies in the development and manufacturing of proteins for drug development, offering a combination of scientific expertise and technological infrastructure.

Excelson SA 

Rossens Fr · Since 2020

The core activity of Excelson SA is the development, manufacture and marketing of innovative audio solutions, particularly soundboards made from sound wood, offering an immersive and touching sound quality. The company combines traditional craftsmanship with modern technology to create unique audio experiences.

Exergie AG 

Rüschlikon · Since 1989

Exergie AG provides energy consulting services including energy analyses, concepts and optimisation for new and existing buildings. Its services include energy balances and simulations, thermal imaging, building physics, technical system planning and sizing, support for certifications (e.g. Minergie), subsidy applications, tendering and construction follow-up, as well as targeted audits and measures for SMEs and public-sector clients.

ExoLabs GmbH 

Zurich · Since 2017

The core activity of ExoLabs is the development of customized software solutions, data products, and scientific know-how based on geospatial and remote sensing data to support customers from the public and private sectors in gaining insights and increasing efficiency at reduced costs. In particular, the company focuses on the processing of satellite data in real-time and the provision of solutions for monitoring environmental resources, such as snow, forest, land use, and land cover.

ExpertInova AG 

Zug · Since 2018

The core activity of Expertinova AG is to evaluate and support innovations and technologies, particularly in the fields of Life Science, Biotech and Med-Tech. The company provides expert knowledge and consulting to implement scientific innovations into successful processes and products.

Extrovis AG 

Baar · Since 2016

Extrovis AG is a global Contract Research, Development & Manufacturing Organization (CRDMO) that develops and manufactures complex specialty therapeutics, including sterile antibiotics, oncology and cytotoxic formulations, and female hormone products. The company provides R&D, regulated-market manufacturing (USFDA, EU‑GMP) and supply‑chain and regulatory support across drug substances and finished dosage forms.

Fachkommission für Hochspannungsfragen (FKH) 

Zurich · Since 2012

The company's core activity is the conduct of research and testing activities in the field of high-voltage technology, particularly in the areas of insulation diagnostics, earthing measurements, electromagnetic compatibility (EMC), electromagnetic fields (EMF), power grid transient measurements and power quality analysis. The company also provides technical services such as engineering, consulting and expert opinions, and organizes conferences and training courses. The activities are carried out by an association that focuses on promoting the performance and safety of the electrical power supply and does not pursue any commercial goals.